Acute generalized exanthematous pustulosis induced by hydroxychloroquine: First case report in Canada and review of the literature

Journal of Cutaneous Medicine and Surgery

Volumn 17, Issue 6, 2013, Pages 414-418

  Bailey, Kristy ^a   Mckee, Daniel ^a   Wismer, Judy ^a   Shear, Neil ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; HYDROXYCHLOROQUINE; METHYLPREDNISOLONE; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; STEROID; VANCOMYCIN; ANTIRHEUMATIC AGENT;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ADULT; ARTHRALGIA; ARTICLE; BACTERIAL SKIN DISEASE; BACTERIAL SUPERINFECTION; CANADA; CASE REPORT; CHILL; DISCOID LUPUS ERYTHEMATOSUS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; FEVER; FOOT EDEMA; HUMAN; LETHARGY; LEUKOCYTOSIS; MIDDLE AGED; PRIORITY JOURNAL; PRURITUS; PUNCH BIOPSY; PUSTULAR PSORIASIS; PUSTULE; SKIN EXFOLIATION; SKIN PAIN; SWELLING; SYSTEMIC LUPUS ERYTHEMATOSUS; DIFFERENTIAL DIAGNOSIS; LUPUS ERYTHEMATOSUS, CUTANEOUS; REVIEW; SKIN LUPUS ERYTHEMATOSUS;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ANTIRHEUMATIC AGENTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYDROXYCHLOROQUINE; LUPUS ERYTHEMATOSUS, CUTANEOUS; MIDDLE AGED; ONTARIO;

EID: 84891710713     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.2310/7750.2013.12105     Document Type: Article

References (30)

1. Sidoroff A, Halevy S, Bavinck JN, et al. Acute generalized exanthematous pustulosis (AGEP) - a clinical reaction pattern. J Cutan Pathol 2001;28:113-9, doi:10.1034/j.1600-0560.2001.028003113.x.
2. Burrows NP, Russell Jones RR. Pustular drug eruptions: a histopathological spectrum. Histopathology 1993;22:569-73, doi: 10.1111/j.1365-2559.1993.tb00178.x.
3. Roujeau JC, Bioulac-Sage P, Bourseau C, et al. Acute generalized exanthematous pustulosis: analysis of 63 cases. Arch Dermatol 1991;127:1333-8, doi:10.1001/archderm.1991.01680080069004.
4. Sidoroff A, Dunant A, Viboud C, et al. Risk factors for acute generalized exanthematous pustulosis (AGEP) - results of a multinational case-control study (EuroSCAR). Br J Dermatol 2007;157:989-96, doi:10.1111/j.1365-2133.2007.08156. x.
5. Paradisi A, Bugatti L, Sisto T, et al. Acute generalized exanthematous pustulosis induced by hydroxychloroquine: three cases and a review of the literature. Clin Ther 2008;30:930-40, doi: 10.1016/j.clinthera.2008.05.014.
6. Ohkuma S, Poole B. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc Natl Acad Sci U S A 1978;75:3327-31, doi: 10.1073/pnas.75.7.3327.
7. Hurst NP, French JK, Gorjatschko L, et al. Chloroquine and hydroxychloroquine inhibit multiple sites in metabolic pathways leading to neutrophil superoxide release. J Rheumatol 1988;15:23-7.
8. Katz SJ, Russell AS. Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action. Curr Opin Rheumatol 2011;23:278-81, doi:10.1097/BOR.0b013e32834456bf.
9. Gebhardt M, Lustig A, Bocker T, et al. Acute generalized exanthematous pustulosis (AGEP): manifestation of drug allergy to propicillin. Contact Dermatitis 1995;33:204-5, doi:10.1111/j.1600-0536.1995.tb00553.x.
10. Friedman SJ. Pustular psoriasis associated with hydroxychloroquine. J Am Acad Dermatol 1987;16:1256-7, doi:10.1016/S0190-9622(87)80021-X.
11. Lotem M, Ingber A, Segal R, Sandbank M. Generalized pustular drug rash induced by hydroxychloroquine. Acta Derm Venereol 1990;70:250-1.
12. Assier-Bonnet H, Saada V, Bernier M, et al. Acute generalized exanthematous pustulosis induced by hydroxychloroquine. Dermatology 1996;193:70-1, doi:10.1159/000246211.
13. Evans CC, Bergstresser PR. Acute generalized exanthematous pustulosis precipitated by hydroxychloroquine. J Am Acad Dermatol 2004;50:650-1, doi:10.1016/S0190-9622(03)02733-6.
14. Martins A, Lopes LC, Paiva Lopes MJ, Rodrigues JC. Acute generalized exanthematous pustulosis induced by hydroxychloroquine. Eur J Dermatol 2006;16:317-8.
15. Park JJ, Yun SJ, Lee JB, et al. A case of hydroxychloroquine induced acute generalized exanthematous pustulosis confirmed by accidental oral provocation. Ann Dermatol 2010;22:102-5, doi:10.5021/ad.2010.22.1.102.
16. Lateef A, Tan KB, Lau TC. Acute generalized exanthematous pustulosis and toxic epidermal necrolysis induced by hydroxychloroquine. Clin Rheumatol 2009;28:1449-52, doi:10.1007/s10067-009-1262-4.
17. Saissi EH, Beau-Salinas F, Jonville-Bera AP, et al. [Drugs associated with acute generalized exanthematic pustulosis]. Ann Dermatol Venereol 2003;130:612-8.
18. Degos R, Touraine R, Civatte J, et al. [Erythroderma with appearance of pustular psoriasis during a case of Duhring's disease treated with hydroxychloroquine]. Bull Soc Fr Dermatol Syphiligr 1963;70:129-34.
19. Assier H, Auffret N, Beltzer-Garelly E, et al. [Acute generalized exanthematous pustulosis induced by hydroxychloroquine]. Ann Dermatol Venereol 1993;120:848-50.
20. Bonnetblanc JM, Combeau A, Dang PM. [Hydroxychloroquine PUVA therapy photoinduced acute generalized exanthematous pustulosis]. Ann Dermatol Venereol 1995;122:604-5.
21. Fain O, Stirnemann J, Kettaneh A. [Acute generalized exanthematous pustulosis included by hydroxychloroquine during lupus]. Rev Prat 2010;60:20.
22. Djennane M, Tablit I, Billhot M, et al. [Acute generalized exanthematic pustulosis induced by hydroxychloroquine: case report]. Rev Med Interne 2010;31:e7-8.
23. Wallace DJ. The history of antimalarials. Lupus 1966;5 Suppl 1: S2-3.
24. Salido M, Joven B, D'Cruz DP, et al. Increased cutaneous reactions to hydroxychloroquine (Plaquenil) possibly associated with formulation change: comment on the letter by Alarcón. Arthritis Rheum 2002;46:3392-6, doi:10.1002/art.10565.
25. Callaly EL, FitzGerald O, Rogers S. Hydroxychloroquine-associated, photo-induced toxic epidermal necrolysis. Clin Exp Dermatol 2008;33:572-4, doi:10.1111/j.1365-2230.2008.02704.x.
26. Murphy M, Carmichael AJ. Fatal toxic epidermal necrolysis associated with hydroxychloroquine. Clin Exp Dermatol 2001;26: 457-8, doi:10.1046/j.1365-2230. 2001.00857-3.x.
27. Meiss F, Helmbold P, Meykadeh N, et al. Overlap of acute generalized exanthematous pustulosis and toxic epidermal necrolysis: response to antitumour necrosis factor-alpha antibody infliximab: report of three cases, J Eur Acad Dermatol Venereol 2007;21:717-9.
28. Goh TK, Pang SM, Thirumoorthy T, et al. Acute generalised exanthematous pustulosis and toxic epidermal necrolysis induced by carbamazepine. Singapore Med J 2008;49:507-10.
29. Munster T, Gibbs JP, Shen D, et al. Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis. Arthritis Rheum 2002;46:1460-9, doi:10.1002/art.10307.
30. Barbaud A, Collet E, Milpied B, et al. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol 2013;168:555-62, doi:10.1111/bjd.12125.